期刊文献+

miR-205抑制人黑素瘤细胞A375侵袭和对MMP2/9蛋白表达的影响 被引量:2

miR-205 on the Invasion Inhibiton and the Effects of MMP2/9 Proteins in Human Melanoma Cell Line A375
下载PDF
导出
摘要 目的研究miR-205对人皮肤黑素瘤细胞系A375的侵袭能力和MMP2,MMP9的影响,探讨miR-205影响黑色素细胞侵袭的机制。方法将miR-205 mimics用阳离子脂质体LipofectamineTM2000转染A375细胞,Transwell侵袭实验检测细胞侵袭能力变化,Western blot和ELISA检测MMP2和MMP9蛋白表达变化。结果 Transwell侵袭实验显示转染miR-205 mimics后细胞的穿膜数(75.21±11.32)明显低于空白对照组(133.20±8.69)及阴性对照组(128.90±7.03),Western blot和ELISA结果均证实miR-205 mimics能明显减低MMP2/9蛋白表达,以上差异均有统计学意义(P均<0.05)。结论 miR-205可能通过减低MMP2和MMP9表达抑制黑素瘤细胞的侵袭能力。 Objective To investigate the effects of miR-205 on invasion and MMP2 and MMP9 expression in human skin malignant melanoma cell lines A375 and further elucidate its action mechanisms. Methods miR-205 mimics were transfected A375 by lipofectamine package. Cell invasion was studied by transwell invasion as- say. MMP2 and MMP9 proteins expression were investigated by western blot and ELISA. Results Transwell invasion assay demonstrated the number of A375 cells in miR-205 mimics group was significantly lower (75.21 + 11.32) than that in control group (133.20 + 8.69) and negative control group (128.90 + 7.03 ) at 48h after transfeetion. Western blot and ELISA confirmed that miR-205 mimics could significantly inhibit the expressions of MMP2/9 protein and secreting. Conclusion miR-205 inhibit the invaion of human skin ma- lignant melanoma cell may be through reduce the expression of MMP2 and MMP9.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第12期1205-1207,1228,共4页 The Chinese Journal of Dermatovenereology
关键词 黑素瘤 miR-205 侵袭 基质金属蛋白酶 Melanoma miR-205 Invasion Matrix metalloproteinase
  • 相关文献

参考文献15

  • 1孙慧娟,胡纯婷,吴共发.miR-205对黑色素瘤A375细胞增殖、黏附和迁移的影响及机制探讨[J].山东医药,2012,52(44):23-25. 被引量:5
  • 2王丽,栗玉珍.黑素瘤的分子发病机制和靶向治疗新进展[J].中国皮肤性病学杂志,2012,26(2):164-166. 被引量:9
  • 3American Cancer Society. Cancer facts & figures,2008 [ R]. Atlanta: A-merican Cancer Society ,2008 : 19 — 20.
  • 4Hanahan D,Weinberg RA. Hallmarks of cancer: the next generation[J], Cell,2011 ,144(5) :646 -674.
  • 5Chamber AF, Matrisian LM. Changing views of the role of matrix metal-loproteinase in metastasis[ J]. Natl Cancer Inst, 1997 ,89 (6) : 1260 -1270.
  • 6Parsons SL, Watson SA, Collins HM, et al. Gelatianse( MMP-2 and-9)expression in gastrointestinal malingancy [ J ]. Br J Cancer, 1998 , 78(11):1495 -1502.
  • 7Hofmann UB, Westphal JR, Van Muijen GN,et al. Matrix metalioprotei-nases in human melanoma[ J]. J Invest Dermatol,2000,115(3) :337 -344.
  • 8Vaisanen A ,Tuominen H, Kallioinen M,et al. Matrix metalloproteinase-2(72 kD type IV collagenase) expression occurs in the early stage ofhuman melanocytic tumour progression and may have prognostic value[J]. J Pathol, 1996,180( 3) :283 -289.
  • 9Vaisanen A,Kallioinen M,Taskinen PJ,et al. Prognostic value of MMP-2 immunoreactive protein(72 kD type IV collagenase) in primary skinmelanoma[J].J Pathol, 1998 ,186( 1 ) :51 -58.
  • 10Kondratiev S,Gnepp DR,Yakirevich E,et al. Expression and progncis-tic role of MMP2 , MMP9 , MMP13 , and MMP14 matrix metalloprotein-ases in sinonasal and oral malignant melanomas [ J ]. Hum Pathol,2008,39(3) :337 -343.

二级参考文献26

  • 1Gray-Schopfer V,Wellbrock C,Marais R.Melanoma biology and new targeted therapy[J].Nature,2007,445(7130):851-857.
  • 2Dhomen N,Marais R.BRAF signaling and targeted therapies in melanoma[J].Hematol Oncol Clin North Am,2009,23(3):529-545.
  • 3Lopez-Bergami P,Fitchman B,Ronai Z.Understanding signaling cascades in melanoma[J].Photochem Photobiol,2008,84(2):289-306.
  • 4McCubrey JA,Steelman LS,Abrams SL,et al.Emerging Raf Inhibitors[J].Expert Opin Emerg Drugs,2009,14(4):633-648.
  • 5McCubrey JA,Steelman LS,Chappell WH,et al.Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resistance[J].Biochim Biophys Acta,2007,1773(8):1263-1284.
  • 6Dahl C,Guldberg P.The genome and epigenome of malignant melanoma[J].APMIS,2007,115(10):1161-1176.
  • 7Goel VK,Lazar A J,Warneke CL,et al.Examination of mutations in BRAF,NRAS,and PTEN in primary cutaneous melanoma[J].J Invest Dermato1,2006,126(1):154-160.
  • 8Halilovic E,Solit DB.Therapeutic strategies for inhibiting oncogenic BRAF signaling[J].Curr Opin Pharmacol,2008,8(4):419-426.
  • 9Yann Cheli,Mickae Ohanna,Robert Ballotti,et al.Fifteen-year quest for microphthalmia-associated transcription factor target genes[J].Pigment Cell Melanoma Res,2010,23(1):27-40.
  • 10Kenji Kido,Hidetoshi Sumimoto,Sakiyo Asada,et al.Simultaneous suppression of MITF and BRAFV600E enhanced inhibition of melanoma cell proliferation[J].Cancer Science,2009,100(10):1863-1869.

共引文献12

同被引文献7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部